Head, Access Strategy, HEOR and Pricing

About the role

Novartis is looking for a Head of Access Strategy, HEOR and Pricing to join its Value & Access team in Seoul. The role shapes how breakthrough innovations reach patients worldwide by building market access strategies that turn science into value for payers, healthcare systems and patients. It is listed as a hybrid position.

Key responsibilities

• Develop and deliver access strategy and execution for compounds and brands across the research, development and commercialisation continuum
• Articulate product differentiation relevant to payers, patients and healthcare stakeholders, from target population and endpoints to comparators and health economics data
• Ensure access input is reflected in TPPs, clinical programmes, BD&L assessments, asset maximisation and indication sequencing
• Identify evidence needs beyond registration studies and work with HEOR and PCO to deliver high-quality, cross-franchise evidence
• Support country teams in payer negotiations with timely, high-impact materials
• Work with Commercial and Pricing teams to shape international pricing strategy and guidance
• Represent Access with internal partners and external stakeholders across TAs, Medical Affairs, Development, Biomedical Research and S&G

Required profile

• University degree in life sciences, health economics, public health, business or a related field; advanced degree preferred
• At least 10 years of extensive experience in market access, pricing or related disciplines in the pharmaceutical industry
• Proven leadership experience managing teams
• Track record of developing integrated access and pricing strategies for innovative medicines across their lifecycle
• Experience engaging with payers, HTA bodies, health authorities and other external decision-makers
• Strong cross-functional leadership in matrix environments, with strong negotiation, stakeholder management and value story communication skills

Required skills

• Health economics and health technology assessment (HTA)
• Pipeline and early access strategy, including evidence needs and clinical design
• Analytical, strategic and scenario-planning capabilities
• Project management, public affairs and regulatory compliance awareness